Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of infiltrated mepivacaine as a local anesthetic prior to arterial puncture
2025-522974-35-00Phase 4Authorised
- Sponsor
- University of the Basque Country
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mepivacaine in bronchopulmonary diseases (3 arms), sponsored by University of the Basque Country. Primary endpoint: Pain reduction during arterial puncture. Planned start Jan 2026; status: authorised.
02
Drugs
mepivacaine
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on 2025-522974-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522974-35-00.